Ricordi is the Stacy Joy Goodman Professor and Director of the Diabetes Research Institute and the Cell Transplant Center, at the University of Miami. He developed the method for pancreatic islet isolation now used worldwide and ranked as #1 world expert in islet transplantation for treatment of diabetes (2008-2018). He served as Chairperson of the NIH Clinical Islet Transplantation (CIT) Consortium, which standardized cell manufacturing and completed the first multicenter FDA Phase III trials of islet transplantation in the US.  He was recently inducted into the National Academy of Inventors for contributing outstanding inventions that have made a tangible impact on quality of life, economic development, and welfare of society, and was appointed to the Supreme Council of Health of Italy. Research interests include reversal of autoimmunity, transplant tolerance, modulation of inflammation and regenerative medicine to prevent disease and to prolong healthspan. Ricordi has been awarded 27 patents, has >1,000 scientific publications, >45,000 citations and a 99 H-index.